fda glp-1 compounding warning october 2025 Sends Letters to More Than 50 Compounders and Manufacturers FDA warns 30 telehealth firms

Mahyar Etminan, an epidemiologist at the University of British Columbia and senior author of the study, said up to two per cent of patients who used semaglutide and liraglutide medications to lose weight developed gastrointestinal problems

Mounjaro is only approved to treat type 2 diabetes

A typical strategy is a short trial, evaluate response, then repeat cycles as clinically indicated while addressing lifestyle and underlying drivers

Telehealth platforms and cash-pricing programs can help bridge the gapoften with more predictable costs and ongoing clinical support

Duodenal fistula leaking through skin defect and still open duodenal defect at 2 weeks following fistula creation by anastomosis between the skin and duodenum defect ( c )